Gentlepeople:

Please allow me to introduce you to Medifast Nutrition and Weight Management Products. Medifast Plus® for Diabetics is a Patented U.S. Product.

Thank you for your consideration.

                                                Fred A. Catalano
        Medifast04@msn.com

MEDIFAST® PLUS FOR DIABETICS
U.S. PATENTED PRODUCT
JOHNS HOPKINS UNIVERSITY STUDY SHOWS TYPE II DIABETICS LOST TWICE AS MUCH WEIGHT USING MEDIFAST ®AS THOSE ON AN ADA DIET. Patients on the Medifast® program were able to significantly reduce or eliminate their medicines, including insulin. To order & information 1-800-638-7867 or www.medifastdiet.com.


BuyUSA MEMBER-Medifast04@msn.com
Products available for Export or Joint venture

PRODUCT INFORMATION


MEDIFAST PRODUCTS BACKED UP BY CLINICAL STUDIES
www.medifast.com

ORDER
All products ordered www.medifastdiet.com as samples will be sold at 50% below Retail plus cost of shipping, payment to accompany order. Thank You.

MEDIFAST®PLUS FOR DIABETICS

U.S. PATENTED PRODUCT

For Immediate Dissemination                 March , 2004

JOHNS HOPKINS UNIVERSITY STUDY SHOWS TYPE II DIABETICS LOST TWICE AS MUCH WEIGHT USING MEDIFAST AS THOSE ON AN ADA DIET

Dated: December 26, 2003

Medifast, Inc. recently announced the preliminary 34-week results from its one year and 34-week diabetes study conducted by the Johns Hopkins Bloomberg School of Health.

Preliminary results of the study show that those study volunteers on the Medifast Diet for Diabetics lost twice as much weight as compared to those following basic nutrition recommendations from the American Diabetes Association (ADA).

Study results show that those on the Medifast Diet for Diabetics program lost an average of 16 pounds versus the ADA diet group that lost an average of 8 pounds. Additionally, two-thirds of those on the Medifast program lost at least 5% of their weight, which is a standard measure of the Federal Drug Administration’s (FDA) threshold to indicate clinically significant weight loss, versus one-quarter of those on the ADA diet.

Compliance data indicates that almost twice as many people on the Medifast program were able to complete the weight loss portion of the study.

“These results suggest that the Medifast diet was easier to adhere to than the comparison diet,” says Dr. Larry Cheskin, the principal investigator and Hopkins study examiner. “These results may be important for people who are overweight and have Type II Diabetes. We’re telling people they need to lose weight and manage their diet or risk serious health consequences, so it is useful to study what weight loss method is most effective.”

Medifast asked Dr. Cheskin to conduct a study after receiving numerous reports from patients that Medifast products helped control their diabetes symptoms.

“I have been a diabetic for about five or six years. As of today I am completely off all my sugar and cholesterol medications and my blood pressure is normal. My total weight loss on this program has been 50 pounds. I’ll tell you, this has made the difference to me in life and death. I truly believe Medifast has been a miracle in my life,” says Josephine Shaw, a diabetic patient who worked closely with Medifast’s Medical Director, Dr. Wayne Andersen.

“In my twenty years as a critical care physician using surgery and medicines, I have never experienced the amazing improvements in disease that I have in the two years we have been focused on nutritional intervention as the first line defense against disease,” says Dr. Anderson. “Within 4 to 16 weeks our patients are coming off their cholesterol and diabetic medication and showing dramatic improvements in the symptomentology of several other conditions.”

The researchers randomized two groups of Type II diabetic volunteers. One group was given the Medifast Plus for Diabetics defined-formula meal replacement diet of soups, oatmeal, bars and a variety of shakes. The other group was asked to follow a diet based on ADA nutrition guidelines, shop for their own food and manage their own portions, but had the same guidance from the doctors, counselors and dietitians in the study as the Medifast group.

The study found those randomized to the Medifast program had an average 7.5% decrease in body fat, a clinically significant amount.

In addition to weight loss, the initial results are that Medifast participants sustained an average 9% decrease in blood fasting glucose and an average 19% decrease in insulin levels. Medifast participants also achieved an average 12% decrease in fasting triglycerides, and an average 9% increase in HDL (good) cholesterol. Their levels of systolic and diastolic blood pressure decreased significantly.

What’s more, a number of patients in the Medifast group were able to significantly reduce the number and dose of their medicines. Participants on the Medifast diet saw an average of 27% improvement in their Health Related Quality of Life, which measures such things as physical functioning, energy levels and general health.

“Until now, drug therapy has been the gold standard for diabetics. These results suggest that nutritional therapy could be more effective early on, reduce cost and provide better health for diabetics,” said Brad MacDonald, Medifast’s CEO.

‘If diabetics are being told to lose weight, initial results show that they may be better off on a portion controlled, defined-formula diet,” said Dr. Cheskin. “This is important information for Type II diabetics seeking weight loss.”



MEDIFAST ®JOHNS HOPKINS UNIVERSITY STUDY CONCLUDED - PRELIMINARY
DR. LAWRENCE CHESKIN, MD
TYPE II Diabetics

1. Patients on the Medifast program of portion – controlled foods (that are specially formulated for diabetics) lost weight more quickly than those on the American Diabetics Association diet.

2. Patients on the Medifast program were able to significantly reduce or eliminate their medicines, including insulin.

3. Patients following the American Diabetes Association (ADA) dietary guidelines didn’t lose as much weight, were slower to lose weight and didn’t reduce or eliminate as much medication during the study.

BENEFITS OF MEDIFAST® PLUS FOR DIABETICS

● Low Sugar-less than 6 grams per serving
● Low Calorie
● Low Fat
● Low Glycemic Index
● Low Cholesterol
● Great Tasting
● Rich in Calcium and Iron
● High in Soy Protein
● Excellent Source of Soluble Fiber
● Enriched with 24 Essential Vitamins and Minerals

Medifast Plus Diabetic Products are LOW GLYCEMIC, Certified By The Glycemic Research Institute-Washington, D.C. Visit: www.medifastdiet.com to order & latest information. For further information & commercial orders: Contact: Medifast04@msn.com .


MEDIFAST PRODUCTS PART OF NATIONAL INSTITUTES OF OBESITY STUDY

February 1998 the Medifast weight management products were used by patients enrolled in a National Institutes of Health (NIH) Obesity Research Study being conducted by the University of Vermont in Burlington, VT in collaboration with Johns Hopkins University in Baltimore, Maryland.

Medifast products were used as part of the study’s 1100-1300 calorie weight loss program that obese patients follow to reduce down to their ideal weight.

Preliminary results showed that of the 15 or so patients who completed the study, the average weight loss was approximately 45lbs. With some individuals losing as much as 65-80lbs. Ms.. Amy Turner, RD, the registered dietitian who is in charge of the dietary component of the study states that “the patients love the taste of both the Medifast and Take Shape shakes and I’ve had no complaints.”

Resarchers at the University of Vermont chose to use Medifast products in the study based on the recommendation of Dr. Lawrence Cheskin, Director of the Weight Management Center at Johns Hopkins University. Dr. Cheskin has used Medifast products (shakes, bars, creamy soups, hot cocoa, crackers) at the Weight Management Center for over 8 years and has been quite satisfied with them. Brad MacDonald, CEO of Medifast says, “Medifast offers consumers ‘clinically tested’; weight management products that work.”       

MEDIFAST PRODUCTS QUALIFY TO MAKE THE HEALTH CLAM FOR SOY: “May Reduce the Risk of Heart Disease” AS APPROVED BY THE FDA.                               
THE JOHNS HOPKINS UNIVERSITY - Abstract
During a multi-center evaluation of health benefits and weight loss on the Medifast Weight Management Program, doctors Crowell, M.D. and Cheskin, L.J. The Johns Hopkins University School of Medicine conducted a 16-week analysis of 185 people using the Medifast program.

Findings: Males lost an average of 67.41 lbs. (as much as 121 lbs.) and females lost an average of 47.5 lbs., during fasting. Ninety-one (91%) percent of males and 72% of females lost more that 40 lbs. on the program. Significant reduction were seen in systolic and diastolic blood pressure, total cholesterol and triglycerides. Blood pressures were normalized in 90% of hypertensive patients. Only minor, transient side effects were seen during the modified fast. The most common complaints were headaches, fatigue, lightheadedness, and cold intolerance.

Conclusion: Medically-supervised, protein-sparing modified fast (the Medifast program) offer a safe, effective means of weight reduction and are accompanied by significant improvement in coexisting health problems MEDIFAST®PRODUCTS BACKED UP BY CLINICAL STUDIES